首页|贝那普利联合氨氯地平对原发性高血压患者的疗效及肠道微生态的影响

贝那普利联合氨氯地平对原发性高血压患者的疗效及肠道微生态的影响

扫码查看
目的 探讨贝那普利联合氨氯地平对原发性高血压患者的疗效及对肠道微生态的影响.方法 选取2020年3月至2023年3月郑州市第七人民医院收治的165例原发性高血压患者,采用随机数字表法分为对照组(n=83,氨氯地平治疗)与观察组(n=82,贝那普利联合氨氯地平治疗).比较两组患者治疗前后24 h血压(收缩压、舒张压)、脂代谢[甘油三酯(TG)、总胆固醇(TC)]、内皮功能[内皮素-1(ET-1)、一氧化氮(NO)]、炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)及C反应蛋白(CRP)]及肠道菌群(拟杆菌、乳杆菌、肠杆菌、肠球菌)、物种多样性及丰富度指数(Shannon指数、Ace指数、Chaol指数)].另观察两组不良反应情况.结果 治疗后,观察组收缩压[(121.67±12.54)mm Hg(1 mm Hg≈0.133 kPa)vs(132.85±14.38)mm Hg,t=5.320,P<0.001]、舒张压[(72.21±8.34)mm Hg vs(83.74±9.57)mm Hg,t=8.246,P<0.001]均低于对照组;观察组脂代谢指标均低于对照组[血清TG(1.24±0.21)mmol·L-1 vs(1.56±0.28)mmol·L-1,血清TC(3.47±0.62)mmol·L-1 vs(4.23±0.76)mmol·L-1,t=3.111,7.034,均P<0.05];观察组血清ET-1、CRP、IL-6、TNF-α水平均低于对照组(t=5.567,8.408,4.864,7.215,均P<0.05);观察组厚壁菌门和变形菌门相对丰度[(15.36±2.43)%vs(16.19±2.11)%,(3.42±1.01)%vs(3.96±0.96)%,t=2.344,3.520,均P<0.05]、肠杆菌、肠球菌数量均低于对照组[(8.22±1.36)log10 CFU·g-1 vs(9.16±1.45)log10 CFU·g-1,(7.87±0.96)log10 CFU·g-1 vs(8.59±1.18)log10 CFU·g-1,t=4.294,4.296,均P<0.05].治疗后,观察组血清NO水平高于对照组[(46.12±8.53)μmol·L-1 vs(35.49±7.45)μmol·L-1,t=8.529,P<0.05];观察组拟杆菌[(10.23±1.55)μmol·L-1 vs(9.15±1.42)μmol·L-1]、乳杆菌[(6.82±1.28)μmol·L-1 vs(6.05±1.16)μmol·L-1]、Ace指数[(556.29±86.43)vs(475.35±75.68)]、Chao l指数[586.67±81.64)vs(493.45±72.34)]及Shannon指数[(6.28±1.16)vs(5.58±0.95)]均高于对照组[t=4.668,4.050,6.402,7.765,4.243,均P<0.05).结论 贝那普利联合氨氯地平治疗原发性高血压患者能明显降低血压血脂水平,改善内皮功能,抑制炎症反应,调节肠道微生态环境,且具有良好的安全性.
Effect of benazepril combined with amlodipine on intestinal microecology in patients with essential hypertension
Objective To explore the efficacy of benazepril combined with amlodipine in treatment of patients with essential hypertension and its impact on intestinal microecology of the patients.Methods A total of 165 patients with essential hyperten-sion treated in Zhengzhou Seventh People's Hospital from March 2020 to March 2023 were enrolled in this study and divided into the control group(n=83,treated with amlodipine)and the observation group(n=82,treated with benazepril and amlodipine).The 24 h mean blood pressure(systolic and diastolic blood pressure),lipid metabolism(triglyceride(TG),total cholesterol(TC)),endothelial function(endothelin-1(ET-1),nitric oxide(NO)),inflammatory factors(tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)and C-reactive protein(CRP))and intestinal microecology(changes of intestinal flora(Bacteroides,Lactobacillus,Enterococcus)),species diversity and richness indexes(Shannon index,Ace index,Chaol index))were compared between the two groups before and after treatment.The rate of adverse reactions was calculated in both groups.Results After treatment,the systolic blood pressure((121.67±12.54)mm Hg(1 mm Hg≈0.133 kPa)vs(132.85±14.38)mm Hg(1 mm Hg≈0.133 kPa))and the diastolic blood pressure((72.21±8.34)mm Hg vs(83.74±9.57)mm Hg)in the observation group were both lower than those of the control group(t=5.320,8.246,both P<0.001).The lipid metabolism indicators in the observation group were lower than that in the control group(serum TG(1.24±0.21)mmol∙L-1 vs(1.56±0.28)mmol·L-1,serum TC(3.47±0.62)mmol∙L-1 vs(4.23±0.76)mmol∙L-1,t=3.111,7.034,both P<0.05).The levels of serum ET-1,CRP,IL-6,and TNF-α in the observation group were lower than those in the control group(t=5.567,8.408,4.864,7.215,all P<0.05).The relative abundance of Firmicutes and Proteobacteria((15.36±2.43)%vs(16.19±2.11)%,(3.42±1.01)%vs(3.96±0.96)%,t=2.344,3.520,both P<0.05),as well as the number of Escherichia coli and Enterococ-cus((8.22±1.36)log10 CFU·g-1 vs(9.16±1.45)log10 CFU·g-1,(7.87±0.96)log10 CFU·g-1 vs(8.59±1.18)log10 CFU·g-1,t=4.294,4.296,both P<0.05)in the observation group were all lower than those in the control group.After treatment,the serum NO level in the ob-servation group was higher than that in the control group((46.12±8.53)μmol·L-1 vs(35.49±7.45)μmol·L-1,t=8.529,P<0.05).The observation group showed higher levels of Bacteroides((10.23±1.55)μmol·L-1 vs(9.15±1.42)μmol·L-1),Lactobacillus((6.82±1.28)μmol·L-1 vs(6.05±1.16)μmol·L-1),Ace index((556.29±86.43)vs(475.35±75.68)),Chao l index((586.67±81.64)vs(493.45±72.34)),and Shannon index((6.28±1.16)vs(5.58±0.95))as compared with the control group(t=4.668,4.050,6.402,7.765,4.243,all P<0.05).Conclusion Benazepril combined with amlodipine in the treatment of patients with essential hypertension can ob-viously reduce blood pressure and blood lipid levels,improve endothelial function,inhibit inflammatory reaction and regulate intestinal mi-cro-ecological environment.Meanwhile,it is of high safety.

BenazeprilAmlodipineEssential hypertensionIntestinal microecologyCurative effect

夏开、张华、张宇、厉菁

展开 >

郑州市第七人民医院心内科六病区,郑州 450000

贝那普利 氨氯地平 原发性高血压 肠道微生态 疗效

河南省医学科技攻关计划项目

LHGJ20220830

2024

中国药物应用与监测
中国人民解放军总医院

中国药物应用与监测

CSTPCD
影响因子:1.983
ISSN:1672-8157
年,卷(期):2024.21(4)